Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention
@inproceedings{CantosVillar2011AntioxidantAO, title={Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention}, author={E. Cantos-Villar and P. Zafrilla and J. Mulero}, year={2011} }
Increasing evidence demonstrates that oxidative stress causes damage to cell function with aging and is involved in a number of age related disorders including atherosclerosis, arthritis, and neurodegenerative disorders. Cellular changes show that oxidative stress is an event that precedes the appearance of the hallmark pathologies of the disease, neurofibrillary tangles and senile plaques. Although excessive consumption of ethanol in alcoholic beverages causes multi-organ damage, moderate… CONTINUE READING
References
SHOWING 1-10 OF 124 REFERENCES
Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
- Medicine
- Molecular Neurobiology
- 2010
- 252
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.
- Chemistry, Medicine
- European journal of pharmacology
- 2006
- 591
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
- Chemistry, Medicine
- The Journal of nutritional biochemistry
- 2006
- 267
- PDF
Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration.
- Biology, Medicine
- Journal of Alzheimer's disease : JAD
- 2009
- 101
Oxidative stress and Alzheimer disease.
- Chemistry, Medicine
- The American journal of clinical nutrition
- 2000
- 977
- Highly Influential
- PDF
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
- Biology, Medicine
- Neurochemistry International
- 2009
- 397
Resveratrol—A boon for treating Alzheimer's disease?
- Biology, Medicine
- Brain Research Reviews
- 2006
- 298
- PDF
Oxidative stress in Alzheimer disease: A possibility for prevention
- Biology, Medicine
- Neuropharmacology
- 2010
- 367